Cleared Traditional

K090223 - ICAD BREAST INTERVENTIONAL PLANNING SOFTWARE, MODEL D70024

K090223 is an FDA 510(k) clearance for ICAD BREAST INTERVENTIONAL PLANNING SOF..., manufactured by Icad, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K090223 · Icad, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2009
Decision
60d
Days
Class 2
Risk

K090223 is an FDA 510(k) clearance for the ICAD BREAST INTERVENTIONAL PLANNING SOFTWARE, MODEL D70024. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Icad, Inc. (Nashua, US). The FDA issued a Cleared decision on March 31, 2009 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Icad, Inc. devices

FDA 510(k) Submission Details - K090223

510(k) Number K090223 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 2009
Decision Date March 31, 2009
Days to Decision 60 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 107d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2129
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K090223.
MD213MG 21.3 DIAGNOSTIC IMAGING LCD MONITOR - L218TL
K090215 · Nec Display Solutions , Ltd. · Apr 2009
MD213MC 21.3 DIAGNOSTIC IMAGING LCD MONITOR MODEL, L218TJ
K090218 · Nec Display Solutions , Ltd. · Apr 2009
CARDIAC FUNCTION ANALYSIS, CALCIUM SCORING
K083446 · Ziosoft, Inc. · Mar 2009
VRAD PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM SOFTWARE
K090649 · Virtual Radiologic Corporation · Mar 2009
BRIT PACS SYSTEMS
K081168 · Brit Systems, Inc. · Mar 2009
DEMASQ IMAGING SPFTWARE DEVICE
K090481 · Demasq Limited · Mar 2009